APA (7th ed.) Citation

Kopka, K., & Haberkorn, U. (2017). Glu-ureido-based inhibitors of prostate-specific membrane antigen: Lessons learned during the development of a novel class of low-molecular-weight theranostic radiotracers. Journal of nuclear medicine, 58, . https://doi.org/10.2967/jnumed.116.186775

Chicago Style (17th ed.) Citation

Kopka, Klaus, and Uwe Haberkorn. "Glu-ureido-based Inhibitors of Prostate-specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-molecular-weight Theranostic Radiotracers." Journal of Nuclear Medicine 58 (2017). https://doi.org/10.2967/jnumed.116.186775.

MLA (9th ed.) Citation

Kopka, Klaus, and Uwe Haberkorn. "Glu-ureido-based Inhibitors of Prostate-specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-molecular-weight Theranostic Radiotracers." Journal of Nuclear Medicine, vol. 58, 2017, https://doi.org/10.2967/jnumed.116.186775.